University of California San Francisco

Katharine Striedinger Pomerantz
Katharine
Striedinger Pomerantz
MD, PhD

Laboratory Manager, 2019 - 2024
Associate Researcher, UCSF

Biography

Biomedical scientist, clinician and entrepreneur with 12 years of experience fired up in the quest of using stem cell research towards regeneration and quality human health-span.

Education

Institution Degree Dept or School End Date
University of Washington Certificate in Clinical Studies Clinical Studies 12/2009
University of California San Francisco - Postdoc Brain tumor Meningioma 06/2008
Albert Einstein School of Medicine Postdoc Neural Stem Cells 01/2005
International Graduate School PhD Neuroscience 12/2004
MD Medical School of Colombia MD Medicine 12/1999
University of California San Francisco postdoc Human Muscle Stem Cells

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 12
  1. Rodent Model of Masseter Volumetric Muscle Loss for Studying Bioengineering Materials.
    Rohrer L, Striedinger K, Pomerantz J| | PubMed
  2. Loss of transcriptional heterogeneity in aged human muscle stem cells.
    Barruet E, Striedinger K, Marangoni P, Pomerantz JH| | PubMed
  3. Purification and preservation of satellite cells from human skeletal muscle.
    Striedinger K, Barruet E, Pomerantz JH| | PubMed
  4. Satellite cell activation and retention of muscle regenerative potential after long-term denervation.
    Wong A, Garcia SM, Tamaki S, Striedinger K, Barruet E, Hansen SL, Young DM, Pomerantz JH| | PubMed
  5. Functionally heterogeneous human satellite cells identified by single cell RNA sequencing.
    Barruet E, Garcia SM, Striedinger K, Wu J, Lee S, Byrnes L, Wong A, Xuefeng S, Tamaki S, Brack AS, Pomerantz JH| | PubMed
  6. From gut to glutes: The critical role of niche signals in the maintenance and renewal of adult stem cells.
    Trentesaux C, Striedinger K, Pomerantz JH, Klein OD| | PubMed
  7. The carboxyl-terminal domain of connexin43 is a negative modulator of neuronal differentiation.
    Santiago MF, Alcami P, Striedinger KM, Spray DC, Scemes E| | PubMed
  8. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
    Striedinger K, VandenBerg SR, Baia GS, McDermott MW, Gutmann DH, Lal A| | PubMed
  9. Interleukin-1beta affects calcium signaling and in vitro cell migration of astrocyte progenitors.
    Striedinger K, Scemes E| | PubMed
  10. Exocytosis of ATP from astrocyte progenitors modulates spontaneous Ca2+ oscillations and cell migration.
    Striedinger K, Meda P, Scemes E| | PubMed
  11. Loss of connexin36 increases retinal cell vulnerability to secondary cell loss.
    Striedinger K, Petrasch-Parwez E, Zoidl G, Napirei M, Meier C, Eysel UT, Dermietzel R| | PubMed
  12. Fine-structural analysis and connexin expression in the retina of a transgenic model of Huntington's disease.
    Petrasch-Parwez E, Habbes HW, Weickert S, Löbbecke-Schumacher M, Striedinger K, Wieczorek S, Dermietzel R, Epplen JT| | PubMed